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Objective: Postthrombotic syndrome (PTS) develops in 40% to 60% of patients with deep venous thrombosis. Factors that
are important in the development of PTS include venous reflux, deep vein obstruction, and calf muscle pump dysfunction
(CMD).
Methods: Reflux and CMD in relationship to the severity of PTS were evaluated in a 2-year follow-up study of patients with
acute deep venous thrombosis. Duplex scanning was used to measure reflux. The supine venous pump function test
(SVPT) measures CMD with strain-gauge plethysmography. The base-line examination was performed within 1 to 5 days
after diagnosis. The next examinations were scheduled at 3, 6, 12, and 24 months.
Results: The study included 86 legs, and the 2-year follow-up period was completed for 70 legs. Significantly more reflux
was found in previously thrombosed vein segments, with an odds ratio of 1.8 after 3 months, of 2.1 after 6 months, of
2.5 after 12 months, and of 3.2 after 24 months. Multiple regression results showed that the most important risk factor
for early clinical signs of PTS was superficial reflux in months 3, 6, and 12 (P < .02). Deep reflux did not have a synergistic
relationship with superficial reflux in correlation with the clinical signs of PTS. The SVPT was not able to predict the
development of PTS.
Conclusion: More reflux develops in previously thrombosed vein segments. As early as after the third month, patients with
superficial reflux have an increased risk of development of the first clinical signs of PTS. Within 2 years, the SVPT shows
no relationship with clinical signs of PTS. (J Vasc Surg 2002;35:1184-9.)
Acute deep venous thrombosis (DVT) may cause per-
sistent venous abnormalities. In 40% to 60% of patients,
DVT develops into postthrombotic syndrome (PTS).1,2
This chronic syndrome varies from scarcely visible skin
changes to pain and recurrent ulcerations, which in rare
cases even can lead to amputation.3 The social and eco-
nomic burden of postthrombotic complications are consid-
erable.4
The pathophysiology of PTS is not entirely under-
stood. Factors that are probably important in the develop-
ment of PTS are venous reflux,5-11 deep vein obstruction,12
and calf muscle pump dysfunction (CMD).13-15 CMD can
be evaluated with plethysmography.13,14,16-19 The pres-
ence and location of venous reflux can be measured with
duplex scanning.8,9,20-23 Both tests are noninvasive, and
therefore, serial examinations are possible. Plethysmogra-
phy measures the global hemodynamics,21 and duplex
scanning can be used to localize the venous abnormali-
ties.22 Duplex scanning is reliable in the detection of reflux
and even might be a better method for the detection of
reflux than phlebography.20 In a previous article, the de-
velopment of PTS in relationship to the evolution of DVT
and residual persistent outflow obstruction was described
in the same patient database.24 The purpose of this study
was the evaluation of the development of PTS in relation-
ship to venous reflux and CMD in a 2-year follow-up study
of patients with acute DVT.
METHODS
Between 1995 and 1998, all patients with acute DVT
who underwent diagnosis at the radiology department and
gave informed consent were included in the study. The
study was approved by the ethics committee of the hospital
and all patients. At the vascular laboratory, the detailed
baseline examination used in the follow-up study was per-
formed within 1 to 5 days after diagnosis.
All patients were prospectively included in a follow-up
program and underwent treatment with heparin (65 of 86
cases; 76%) or low molecular weight heparin (21 of 86
cases; 24%) administered for at least 5 days during the acute
phase, which was continued until the simultaneous start of
treatment with oral anticoagulation (OAC) therapy re-
sulted in an international normalized ratio (INR) between
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2 and 3 during 2 consecutive days. Patients underwent
treatment for 3 months, except the patients with pulmo-
nary embolism or continuing risk factors (such as malignant
disease) who underwent treatment for a longer period of
time. The OAC therapy was continued for 3 months in 50%
of the cases (43 of 86), for 6 months in 22% (19 of 86), for
1 year in 9% (8 of 86), and for 24 months in 9% (16 of 86).
Adequate anticoagulation therapy with the coumarin deriv-
ative accenocoumarol was defined as an INR value of 2 or
more within 4 days after the diagnosis.
Initially, compression therapy was applied for at least 5
days or longer until the leg showed no edema. At this time,
all patients were instructed and motivated at each visit to
wear graduated custom-made compression stockings for at
least 1 year. A compete medical history was obtained. The
evaluated thrombotic risk factors were immobilization, ma-
lignant disease, factor V mutation, surgery, and pregnancy
or recent delivery.
A physician, blinded to the findings of the duplex
scanning and plethysmography, quantified PTS in the pa-
tients at 1 and 2 years after DVT according to the seven-
point CEAP clinical scale (Clinical, Etiologic, Anatomic,
Pathophysiologic; range, 0 to 6) of the Ad Hoc Committee
on Reporting Standards in Venous Disease, the update,25
as shown in Table I. In the evaluation, the 2-year CEAP
score preferably was used. If the patient did not complete
the 2-year follow-up period, the 1-year CEAP score was
used. Recurrent DVT was reported if the patients had new
clinical signs of DVT and if this could independently be
confirmed with a new thrombus with phlebography or
compression ultrasound scanning at the radiology depart-
ment.
Duplex ultrasound scan. Duplex scanning was per-
formed as described previously22 by two experienced vas-
cular technicians with a Toshiba SSA 270A scanner (Tokyo,
Japan) with a 3.75-MHz or 5-MHz probe in low-flow
setting (minimal measurable velocity, 2 cm/s). All veins
were examined with the patient in 45-degree sitting posi-
tion, knees flexed and feet resting on a footstool. The
results of this technique of reflux measurements are com-
parable with those of the cuff deflation technique.23 The
technical advantages (no cuff deflator), comfort for the
patient, and its simplicity were arguments to use this tech-
nique.
The patients underwent scanning by a vascular techni-
cian blinded for the results of previous examinations. The
following 12 vein segments were examined: the superficial
femoral vein (proximal, middle, and distal), the popliteal
vein, the long saphenous vein (proximal, middle, and dis-
tal), the short saphenous vein, and the posterior and ante-
rior tibial veins. In the calf, two veins accompany each
artery. The two veins were numbered, with number 1 being
the most superficial and number 2 the deeper vein. In the
longitudinal plane, the presence of reflux was measured.
Proximally, reflux was measured after Valsalva’s maneuver,
and in the distal veins, reflux was measured with distal
manual compression with sudden release. Pathologic reflux
in the proximal veins was defined as a reversed flow dura-
tion of more than 1 second; in the distal veins, it was a
reversed flow duration of more than 0.5 second. Reflux in
the common femoral vein was not measured because, as
shown in a previous study,22 60% of healthy individuals had
a reflux duration exceeding 1 second with this method.
With this definition and method of inducing reflux, the 
coefficient of the interobserver variability was 0.86.22
Supine venous pump function test. CMD was mea-
sured with the use of the supine venous pump function test
(SVPT), which was performed with strain-gauge plethys-
mography as described previously.13,19 Both feet of the
supine patient rested against a foot support 10 to 15 cm
above the bed, with the knees at an angle of about 120
degrees. Inflatable cuffs were placed around the thighs. The
strain gauges were placed 1 to 2 cm below the origin of the
Achilles tendon, avoiding the most muscular part of the calf
to minimize motion artifacts. The cuffs were inflated, which
resulted in a gradual increase of venous pressure and limb
volume distal to the cuffs. After a maximum increase in
volume was achieved, the patient was instructed to perform
maximal dorsal flexion and plantar flexion of the feet. In
total, 10 repetitions of each movement were performed
during a 20-second period. Because of this muscle pump
action, blood was squeezed past the cuff, which resulted in
a decrease in the volume of the limb. This procedure was
repeated at different cuff pressures of 50, 60, and 70 mm
Hg (performed twice at each pressure).
In addition, a separate pressure-volume relationship
was determined with measurement of the relative increase
in volume at five different cuff pressures of 20, 30, 40, 50,
and 60 mm Hg. With this relationship, the decrease in
volume during exercise could be converted to a decrease in
pressure. The decrease in pressure was expressed as a per-
centage of the initial pressure and was approximately the
same at all cuff pressures. The average percentage pressure
change at all the different cuff pressures in healthy individ-
uals was 60% or more (coefficient of variation, 9%).19
The SVPT was measured because prior studies showed
that patients with severe signs of PTS had abnormal SVPT
Table I. Percentage vein segments (n  12) with reflux
over time (months) as derived from interperiod
correlation matrix (r)
Vein segments
Time (months)
r3 6 12 24
Superficial femoral proximal 41 42 47 36 0.40
Superficial femoral half 29 30 36 33 0.60
Superficial femoral distal 22 23 27 27 0.62
Popliteal 25 26 26 31 0.17
Posterior tibial 1 21 28 27 27 0.48
Posterior tibial 2 22 24 29 26 0.31
Anterior tibial 1 9 9 6 0 –0.07
Anterior tibial 2 9 8 7 7 0.13
Long saphenous proximal 25 24 30 37 0.49
Long saphenous half 22 11 17 13 0.45
Long saphenous distal 25 31 26 23 0.54
Short saphenous 21 12 16 13 0.45
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results (45%). This was assessed in patients 10 years after
DVT.13,19
Statistical evaluation. Reflux was evaluated for the
total score of all 12 vein segments and separately for each
individual vein segment and for the four proximal deep vein
segments (femoral and popliteal), the four superficial vein
segments (long and short saphenous), and the four distal
vein segments (posterior and anterior tibial). The Mantel-
Haenszel test was used to evaluate the odds ratio and 95%
CI for the development of reflux in initially thrombosed
vein segments. For analysis of factors that contributed to
the CEAP score, the following risk factors were tested with
multiple regression: age, venous outflow resistance,24 the
presence of noncompressible vein segments, and the pres-
ence of reflux at each time interval. The relationship be-
tween the reflux over time, the SVPT, and the CEAP
classification with age was studied with partial correlation
coefficients.
The three patients with DVT in two different legs were
considered statistically independent because the time inter-
val between the DVT in both legs was more than 1 year. A
P value .05 or less was considered statistically significant.
RESULTS
In the study, 86 legs of 83 patients with proven DVT
were included. The mean age of the patients was 53 years
(range, 17 to 88 years; standard deviation, 16 years), and
43 patients were male and 40 female. Of the 83 patients, 11
(13%) had prior DVT. In three patients (4%), the prior
DVT was located in the same leg. Thrombosis was unilat-
eral on the right side in 34 patients (41%), unilateral on the
left side in 46 patients (55%), and bilateral in three patients
(4%). The 2-year follow-up period was completed in 70 legs.
Individual risk factors for the initial DVT were immo-
bilization in 17 patients, malignant disease in 13 patients,
factor V mutation in 13 patients, surgery in four patients,
and recent delivery in three patients. In 33 patients (40%),
no risk factors were found.
The mean age of the 16 patients who did not complete
the study was 63 years (range, 30 to 82 years; standard
deviation, 16 years), and seven patients were male and nine
female. Of these 16 patients, five died during the study and
the other 11 were lost for various reasons. Seven of these
patients (44%) had prior DVT. Thrombosis was unilateral
on the right side in seven (44%) and on the left side in nine
(56%). The most common risk factor was malignant disease
in six of the patients (38%).
The distribution of DVT with the standardized exam-
ination of all vein segments at baseline was as follows.
Sixty-eight legs with proximal DVT were found. In 26
(38%), not only proximal DVT, but also superficial throm-
bosis, was found. Of the remaining 18 legs, in eight (44%),
thrombosis was found in the superficial veins as well.
The INR results were available in 73 patients, and in 59
(81%), dosage regiment was adequate and resulted in an
INR of 2 or more within 4 days after the diagnosis. No
major bleeding complications were encountered.
Of the patients in whom new clinical signs developed,
such as a swollen leg or pain, recurrent DVT was diagnosed
by the radiology department in eight patients, five in the leg
initially involved and three in the contralateral leg. Of these
eight patients, two underwent OAC therapy during the
recurrence of DVT. In one patient, nonfatal pulmonary
embolism developed 6 weeks after the 6 months of OAC
treatment was ended.
Table II shows the number of patients and their CEAP
scores at the last follow-up examination after 1 years (n 
9) or 2 years (n 70). Significantly more reflux was found
in previously thrombosed vein segments, with an odds ratio
of 1.8 after 3 months (95% CI, 1.2 to 2.7), of 2.1 after 6
months (95% CI, 1.4 to 3.2), of 2.5 after 12 months (95%
CI, 1.7 to 3.7), and of 3.2 after 24 months (95% CI, 2.1 to
4.9).
Multiple regression results showed that the most im-
portant risk factor for a high CEAP score was superficial
reflux in months 3, 6, and 12 (P .02). In each of the
separate traceable vein segments, the mean of the CEAP
classification was calculated for the vein segments with and
without reflux. Only in the proximal and middle long
saphenous vein was a significantly higher mean CEAP
classification found in the vein segments with reflux in
month 3 (P .03), month 6 (P .01), and month 24 (P
.05).
Table III shows the relationship between the number
of vein segments with deep or superficial reflux over time
and the CEAP classification. No correlation was found with
deep reflux, but superficial reflux was found to be an
increased risk factor for a higher CEAP classification. Deep
reflux did not have a synergistic relationship with superficial
reflux in correlation with the clinical signs of PTS. Each
increasing single vein segment with superficial reflux up-
graded the CEAP score by 0.4.
Table I shows the percentage of the 12 vein segments
with reflux over time. The interperiod correlation matrix
showed no significant increase or decrease in percentage of
reflux over time. The correlations from time to time are
quite variable (–0.07 to 0.60), meaning that the reflux
situation is not stable within patients.
The Figure shows the relationship between the SVPT
and the CEAP classification. The partial correlation coeffi-
cients for age (r) after 24 months was –0.01 (P  1). This
Table II. Number of patients with DVT with and
without clinical signs of postthrombotic syndrome
(CEAP score) at last follow-up examination
CEAP
score* Clinical signs
No. of
patients
0 No visible or palpable signs 18 (23%)
1 Telangiectases, reticular veins, malleolar flare 4 (5%)
2 Varicose veins 15 (19%)
3 Edema, without skin changes 26 (33%)
4 Hyperpigmentation and lipodermatosclerosis 16 (20%)
*No patients had CEAP score 5 or 6.
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means that the SVPT did not enable prediction of the
CEAP classification. No relationship was found after 3
months (r  .1; P  .7), 6 months (r  .2; P  .2), and
12 months (r  .04; P  .7) either.
DISCUSSION
Superficial reflux. In recent years, superficial reflux
was recognized as an important cause of chronic venous
insufficiency.26-31 Shami et al30 reported that in just over
half the patients with venous ulcerations, the insufficiency
was confined to the superficial venous veins. It was also
becoming clear that the presence of pathologic reflux was
important in the development of PTS.29,32 Although in the
study of Labropoulos et al,29 the importance of superficial
reflux in the development of PTS was recognized, our study
not only showed that the most important factor was reflux
and in an increasing number of superficial vein segments
but also that deep reflux plays no synergistic role with
superficial reflux in relationship to the CEAP classification,
within 2 years. Therefore, the presence of deep reflux
seemed less important in the early development of PTS.
This is in accordance with the van Ramshorst et al23 study.
Fig 1. Relationship between 24-month SVPT and final postthrombotic (CEAP) classification.
Table III. Relationship between presence of deep or superficial reflux over time and final postthrombotic syndrome
(CEAP) score
Time
(months)
Mean final CEAP score (SD)
3 6 12 24
No. of vein segments with deep reflux
0 2.0 (1.4) 1.8 (1.3) 1.9 (1.5) 1.4 (1.3)
1 2.3 (1.3) 2.0 (1.5) 2.3 (1.3) 2.2 (1.5)
2 2.1 (1.8) 3.0 (1.2) 1.8 (1.6) 3.4 (0.7)
3 2.5 (1.5) 2.0 (1.4) 3.1 (1.3) 2.6 (1.7)
4 2.9 (1.3) 2.7 (1.7) 3.0 (0.8) 2.4 (1.0)
5 2.0 (1) 2.5 (1.6) 2.5 (1.2) 2.3 (0.6)
6-8 2.0 (1.4) 3.0 (0.7) 3.0 (0.0) 3.0 (0.7)
Correlation* –0.08 0.06 0.17 0.18
P value 0.5 0.6 0.2 0.2
No. of veins segments with superficial reflux
0 1.6 (1.4) 1.7 (1.4) 1.9 (1.5) 1.8 (1.4)
1 2.4 (1.3) 2.5 (1.4) 2.2 (1.3) 2.2 (1.3)
2 2.5 (1.0) 2.8 (1.3) 3.4 (0.7) 2.6 (1.1)
3 4.0 (0.0) 3.7 (0.5) 3.7 (0.6) 4.0 (0.0)
4 4.0 (0.0) † 4.0 (0.7) †
Correlation* 0.37 0.36 0.32 0.33
P value 0.004 0.006 0.01 0.01
*Partial correlation coefficient corrected for age influence.
†No patients had reflux in this number of vein segments.
SD, Standard deviation.
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They found no relationship between the number of incom-
petent deep vein segments and the clinical symptoms after
34 months.
That superficial reflux was common in patients with
DVT could be explained with the distribution of DVT. If
not only the presence of DVT was measured but also the
presence of superficial thrombosis, the superficial vein seg-
ments were shown to be involved in 40% of the patients.
Because significantly more reflux developed in previously
thrombosed veins, reflux also developed in previously
thrombosed superficial vein segments, as also observed by
other investigators.33
As shown in Table I, there is no linear increase during
the follow-up period of the presence of reflux in each vein
segment. This was because the presence of reflux not only
continuously increases over time but may also disappear. In
a preceding study,22 we showed that the  coefficient of the
interobserver variability in the classification of reflux was
good and therefore it was unlikely that this was entirely the
result of a measurement error. In the same database24 and
as found by other investigators,34 propagation was com-
mon. Reflux may disappear because of an occlusion of vein
segments.
Calf muscle dysfunction. The presence of CMD
within 2 years showed no significant relationship with the
severity of the PTS, which is in contrast with a previous
study 10 years after DVT13 and with findings by other
investigators13,35 in patients with venous ulcers, probably
because in this study none of the patients had CEAP scores
of 5 or 6. Apparently, the damage to the calf muscle
function takes more than 2 years. The study of Raju et al36
suggested that in the mechanism leading to CMD, changes
in properties of the vein wall were important. A vein must
be able to collapse to push the blood cranially. It is likely
that the decreasing ability of the vein to collapse is caused
by a stiffening of the vein wall. A decreasing elasticity may
be caused by a high venous pressure induced by an accel-
erated pressure recovery caused by reflux. This mechanism
leading to the damage of the vein wall might take more
than 2 years to develop. Another explanation may be that
the patients with severe clinical signs of PTS have pain and
therefore have the inclination to walk less and therefore
over time an atrophic calf muscle develops. This process
probably also takes more than 2 years.
A limitation of this study that must be recognized is
that none of the patients had CEAP scores of 5 or 6. The
use of graduated compression stockings probably delayed
the development of the more severe signs of PTS. There-
fore, a 2-year follow-up period is a short time in the
development of severe PTS. In a previous study,7 patients
with more severe signs of PTS were measured 10 years after
DVT and showed that reflux in the proximal deep veins
contributed significantly to PTS. Perhaps reflux in the deep
proximal veins becomes increasingly important in patients
with more severe signs of PTS. Furthermore, this study
provided no information about the perforating veins be-
cause other investigators37 showed that duplex scan is
unreliable in the evaluation of perforating veins. Perhaps
development of perforator incompetence takes longer than
2 years. If perforator incompetence develops, possibly
proximal deep reflux does play a synergistic role with super-
ficial reflux in relationship to the severe signs of PTS.
CONCLUSION
Significantly more reflux developed in previously
thrombosed vein segments. As early as after 3 months,
patients with superficial reflux were at risk in development
of the first clinical signs of PTS. Deep reflux did not have a
synergistic relationship with superficial reflux in correlation
with the first clinical signs of PTS. An increasing number of
insufficient superficial vein segments led to an increasing
severity of PTS. Within 2 years, the SVPT showed no
relationship with clinical signs of PTS.
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